QRG Capital Management Inc. Decreases Holdings in Cardinal Health, Inc. $CAH

QRG Capital Management Inc. trimmed its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 78.5% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 30,886 shares of the company’s stock after selling 112,826 shares during the quarter. QRG Capital Management Inc.’s holdings in Cardinal Health were worth $4,848,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently modified their holdings of CAH. Geode Capital Management LLC lifted its holdings in Cardinal Health by 3.3% in the second quarter. Geode Capital Management LLC now owns 6,389,049 shares of the company’s stock valued at $1,069,005,000 after acquiring an additional 205,539 shares during the period. Norges Bank bought a new stake in shares of Cardinal Health during the 2nd quarter valued at about $584,420,000. Invesco Ltd. increased its position in shares of Cardinal Health by 7.3% during the 2nd quarter. Invesco Ltd. now owns 3,037,782 shares of the company’s stock valued at $510,347,000 after purchasing an additional 207,750 shares during the last quarter. Legal & General Group Plc lifted its stake in shares of Cardinal Health by 2.0% in the 2nd quarter. Legal & General Group Plc now owns 2,349,767 shares of the company’s stock worth $394,761,000 after purchasing an additional 45,812 shares during the period. Finally, Marshall Wace LLP boosted its holdings in shares of Cardinal Health by 19.1% in the second quarter. Marshall Wace LLP now owns 1,930,967 shares of the company’s stock worth $324,402,000 after buying an additional 309,335 shares during the last quarter. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Stock Performance

Shares of CAH stock opened at $212.44 on Monday. The stock has a fifty day simple moving average of $205.37 and a two-hundred day simple moving average of $174.80. The firm has a market capitalization of $50.48 billion, a PE ratio of 32.04, a PEG ratio of 1.48 and a beta of 0.65. Cardinal Health, Inc. has a 52-week low of $120.72 and a 52-week high of $215.48.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Thursday, October 30th. The company reported $2.55 EPS for the quarter, beating the consensus estimate of $2.22 by $0.33. Cardinal Health had a negative return on equity of 84.37% and a net margin of 0.68%.The business had revenue of $64.01 billion for the quarter, compared to the consensus estimate of $59.41 billion. During the same period in the previous year, the business earned $1.88 earnings per share. The business’s revenue was up 22.4% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. On average, sell-side analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd were issued a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date of this dividend was Friday, January 2nd. Cardinal Health’s dividend payout ratio (DPR) is 30.77%.

More Cardinal Health News

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Recent earnings and guidance support continued upside — Cardinal beat EPS and revenue last quarter and set FY‑2026 guidance of $9.65–$9.85, which underpins bullish analyst commentary and sentiment.
• Positive Sentiment: Analyst upgrade and higher price target — Wells Fargo raised its price target to $237 and kept an “overweight” rating, signaling institutional confidence and an ~11.6% upside vs. current levels. Wells Fargo raises PT to $237
• Positive Sentiment: Momentum: 52-week high and positive coverage — Zacks notes CAH reached a 52‑week high and highlights fundamentals that could sustain the run, supporting momentum traders. Cardinal Health Hit a 52 Week High
• Neutral Sentiment: Income/dividend profile noted — A TalkMarkets dividend analysis flags CAH as a major distributor with dividend appeal for income investors, but it’s not a near-term price catalyst. Dividend Stock Analysis: Cardinal Health, Inc.
• Neutral Sentiment: Multiple Zacks pieces highlight CAH for earnings-beat potential and strong interest coverage — useful context for investors but not an immediate trigger. Will Cardinal Beat Estimates Again?
• Neutral Sentiment: General market/quote pages note price action — coverage from Globe and Mail and Economic Times provides market/quote context but no new company developments. Analysts Offer Insights on Healthcare Companies
• Negative Sentiment: Profit-taking and valuation concerns pushing a pullback — after the 52‑week high and analyst hype, investors appear to be trimming positions; intraday volume is below average and the stock carries a relatively rich P/E (~32) and other metrics (negative trailing ROE) that may prompt caution.

Analyst Upgrades and Downgrades

A number of analysts have commented on the stock. UBS Group upped their target price on shares of Cardinal Health from $185.00 to $220.00 and gave the company a “buy” rating in a report on Friday, October 31st. Citigroup upgraded shares of Cardinal Health from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $190.00 to $244.00 in a research note on Friday, January 9th. Wells Fargo & Company upped their price objective on Cardinal Health from $221.00 to $237.00 and gave the stock an “overweight” rating in a research note on Thursday. Leerink Partners set a $240.00 price target on Cardinal Health in a report on Tuesday, January 13th. Finally, Robert W. Baird set a $250.00 price target on Cardinal Health in a research report on Wednesday. Fourteen analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $216.33.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.